Altimmune Inc (ALT) Options

ALT, new 52 week low

Thank you so much for your kind reply.👍️👍️👍️

I think after mash data if it’s like last trials you can bet for a deal or buyout

BO soon???

ALT, new 52 week low

Still Holding here
As far as buyout and the OS you're looking at roughly 7 billion = 100 a share
10 billion = 140

As promised I don't see any dilution in the filing. Shorts are in trouble

Float is Locked and over 23 million naked shares Short. Shorts have failed Miserably at shaking out Retail and can't cover without a massive loss.
Price Targets
Partner 50 to 75
Buyout 140 to 200

https://forextv.com/top-news/altimmune-announces-publication-of-clinical-study-of-pemvidutide-in-metabolic-dysfunction-associated-steatotic-liver-disease-masld-in-journal-of-hepatology/

IT'S HAPPENING

Beautiful Bull Flag

Well....not quite but a nice pop anyways this week.

Last chance next week above 20

It's being shorted by its competitors not tutes. . An advisor from Lilly is making the presentations of pemvi data this weekend.its what you know not what some want you to believe.

Not a chance at 60. Shorts are playing this one perfectly. Investors are just not interested in ALT. Good luck.

Shorts looking weak and vulnerable today any trading room with the funds could squeeze this to 60 easy

Goldman Sachs been short stacking here for months and they are hosting the fireside tomorrow. I'm loading up today

Time to admit shorty got this one right! This one is going all the way down.
Merger/ buyout what a joke.

This Wednesday we hope data rules. Give us data 📈

Going long for a year 75 target or 50 plus

So much for my ALT prediction.

The stock slipped to $7 and may be cratering more since it's getting no love.

Maybe ALT is a $5 stock or lower if buyers aren't interested.

mb

Radar. ALT $11- $12

Getting picked up.

mb

ALT over $10
Next day settlement begins 5/28 per SEC mandate

ALT 10Q due 3/27
Next day settlement begins 5/28

patiently waiting.. for sure something in the way of news is right there and it can only be a plus.. i want the buyout.. let say 4 billion.. 80 bucks a share..gl

Buyout? Partnership? In less than 9 trading days we will find out.

BUCKLE UP. going to break 15 soon

a good read
https://www.rcplondon.ac.uk/news/world-obesity-day-let-s-talk-about-drugs

slow and steady is healthy as the data goes as well.. fast weight loss is never good and the deeper dive into the data im sure will find that Alt has a wider profile a safer profile as it relates to muscle loss and bone density. time will tell...in any case the real value here is the undiscovered uses.. wide profile more mkts...long and strong ...

ALT @ $12?

Interesting

mb

institutional ownership from nasdaq site
https://www.nasdaq.com/market-activity/stocks/alt/institutional-holdings

big volume wrong direction for now

a good read
https://finance.yahoo.com/news/weight-loss-drugs-patients-lose-134837816.html

and a few more...

you wont be able to chase this..you either in before the news or outside looking in.. patience of a saint..

driving me nutz but i wont sell this until !!!

Post from another board relevant to ALT:

GLP-1 drugs will_be supply-constrained for_a_few_years, according to the NVO and LLY webcasts at JPM. All in-house and CMO capacity suitable for manufacturing injected GLP-1 drugs is already in service. Moreover, the eventual uptake of oral GLP-1 drugs will not ease the manufacturing bottleneck as much as people might think because the low bioavailability of the oral agents requires large amounts of API.

Altimmune, Inc.
(Nasdaq - ALT) $12/share
Market cap = $644M
Cash = $140M
Cash Burn rate = ($76)/Y
Catalysts:
Pemvidutide - Weight loss drug. Peptide based GLP-1/Glucagon dual receptor agonist. Phase 2 results were respectable. At 48 weeks, for 2.4mg (high dose), weight loss of -15.6% (on the low end of the expected 15-20%)., but comparable to Mounjaro. The TRAEs appear to be less than Mounjaro's. The drug did reduce triglycerides.
HepTCell - an immunotherapeutic for Chronic Hepatitis B. In Phase 2 trials. Next read out could be in April, 2024.

I was wrong ALT is attending the JPM Let's get this deal done.

thanks a lot.. im on a new computer.. id rather have oral surgery than learn a new computer

Data is in check Twitter. Weight loss is a 100 billion market. The results on the liver data show a 100 % reduction of fat at the highest dose. That's a 40 billion market.
Now why is ALT not attending the JPM conference this week? Stay tuned

im hanging around bewteen the two potential mkts for their drug its too crazy to even think out loud lets see what the data says.. if its good or really good. all hell will break out

Float is locked, tutes trying to shake few out but this is a done deal IMO

this is a powder keg...

i believe if they wanted to they could have closed a deal by now but they wait till after the new data.. i wonder why.. there is no way for this to go but way up from here..glta

Been Holding since 6. Buyout or partnership is imminent.

HUGE BUYS NOW 10K BUY $100K BUY $$$$$$$$$$$$$$$$$$

Nice comeback today -I’m back in

WOOOOOOOOOOOW 10K AND 9100 SHARE BUYS 2-$100,000 BUYS $$$$$$$$$$$$$$$$$$$$$$$$$$$$$
BABY MONSTER HERE

got dammmmmmmmmmm. oprah must be buying out the company